Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
С. О. Бачурин, Elena Bovina, A. A. Ustyugov
Medicinal Research Reviews (2017) Vol. 37, Iss. 5, pp. 1186-1225
Closed Access | Times Cited: 279

Showing 26-50 of 279 citing articles:

A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease
Franciele Martini, Suzan Gonçalves Rosa, Isabella Pregardier Klann, et al.
Journal of Psychiatric Research (2018) Vol. 109, pp. 107-117
Closed Access | Times Cited: 73
A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease
Tarana Umar, S. Shalini, Md Kausar Raza, et al.
European Journal of Medicinal Chemistry (2019) Vol. 175, pp. 2-19
Open Access | Times Cited: 72
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 812-839
Open Access | Times Cited: 68
Lawsonia Inermis Markedly Improves Cognitive Functions in Animal Models and Modulate Oxidative Stress Markers in the Brain
Numra Tariq Mir, Uzma Saleem, Fareeha Anwar, et al.
Medicina (2019) Vol. 55, Iss. 5, pp. 192-192
Open Access | Times Cited: 66
Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats
Hani S. Hafez, Doaa A. Ghareeb, Samar R. Saleh, et al.
Psychopharmacology (2017) Vol. 234, Iss. 20, pp. 3037-3053
Closed Access | Times Cited: 65
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Julia E. Gerson, Kathleen Farmer, Natalie Henson, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Nurul Husna Ibrahim, Mohamad Fairuz Yahaya, Wael Mohamed, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 63
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
С. О. Бачурин, E. F. Shevtsova, Галина Ф. Махаева, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 62
Scopolamine-Induced Memory Impairment in Mice: Neuroprotective Effects of Carissa edulis (Forssk.) Valh (Apocynaceae) Aqueous Extract
Sabine Adeline Fanta Yadang, Yvette Nguezeye, Christelle Wayoue Kom, et al.
International Journal of Alzheimer s Disease (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 62
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
Killian Oukoloff, Nicolas Coquelle, Manuela Bartolini, et al.
European Journal of Medicinal Chemistry (2019) Vol. 168, pp. 58-77
Open Access | Times Cited: 61
Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer’s disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation
Галина Ф. Махаева, N. V. Kovaleva, Natalia P. Boltneva, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103387-103387
Closed Access | Times Cited: 60
Role of Post‐translational Modifications in Alzheimer's Disease
Madhu Ramesh, Pushparathinam Gopinath, Thimmaiah Govindaraju
ChemBioChem (2019) Vol. 21, Iss. 8, pp. 1052-1079
Closed Access | Times Cited: 58
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
Chiara Villa, Marialuisa Lavitrano, Elena Salvatore, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 61-61
Open Access | Times Cited: 58
Neurodegenerative Pathways in Alzheimer’s Disease: A Review
A Ramachandran, Subham Das, Alex Joseph, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 5, pp. 679-692
Open Access | Times Cited: 50
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 37
Reboot biomedical R&D in the global public interest
Soumya Swaminathan, Bernard Pécoul, Noor Hisham Abdullah, et al.
Nature (2022) Vol. 602, Iss. 7896, pp. 207-210
Closed Access | Times Cited: 35
DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer’s Disease
Min Xiao, Wei Xiang, Yashu Chen, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 34
Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease
Bhupinder Kumar, Ashish Ranjan Dwivedi, Tania Arora, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 14, pp. 2122-2139
Closed Access | Times Cited: 31
Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
Hyun Woo Lee, Seung Yeon Kim, Youngkwon Jo, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Biopharmaceutical characters and bioavailability improving strategies of ginsenosides
Wenli Pan, Binli Xue, Chulei Yang, et al.
Fitoterapia (2018) Vol. 129, pp. 272-282
Closed Access | Times Cited: 59
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Mara ten Kate, Silvia Ingala, Adam J. Schwarz, et al.
Alzheimer s Research & Therapy (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 55
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
Thaís Aparecida Sales, Ingrid G. Prandi, Alexandre A. de Castro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1829-1829
Open Access | Times Cited: 53
Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities
Małgorzata Girek, Paweł Szymański
Chemical Papers (2018) Vol. 73, Iss. 2, pp. 269-289
Open Access | Times Cited: 52
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Jianping Guo, Ji Cheng, Brian J. North, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 2, pp. 341-358
Open Access | Times Cited: 51

Scroll to top